title: Are threshold levels of signal transduction required for the protective effect of cilostazol against cardiac ischaemia-reperfusion injury?
authors.forename: Flávio
authors.initials: F
authors.lastname: Reis
mesh_terms: D000241:Adenosine / Q000378:metabolism*; D000818:Animals; D002316:Cardiotonic Agents / Q000494:pharmacology*; D000077407:Cilostazol; D006801:Humans; D009203:Myocardial Infarction / Q000378:metabolism*; D009569:Nitric Oxide / Q000378:metabolism*; D026902:Potassium Channel Blockers / Q000494:pharmacology*; D015427:Reperfusion Injury / Q000378:metabolism* / Q000517:prevention & control*; D013777:Tetrazoles / Q000494:pharmacology*
chemical_list: D002316:Cardiotonic Agents; D026902:Potassium Channel Blockers; D013777:Tetrazoles; D009569:Nitric Oxide; D000241:Adenosine; D000077407:Cilostazol